Table 3.
Regression Weights of Study Variables on Outcome Rates of Change From Structural Equation Models
|
Hemoglobin A1c |
Systolic Blood Pressure |
LDL Cholesterol |
||||||
|---|---|---|---|---|---|---|---|---|
| Path | Independent Variable | Dependent Variable | Regression Coefficient (SE) | P Value | Regression Coefficient (SE) | P Value | Regression Coefficient (SE) | P Value |
| b3 | PDMa | Patient activation follow-upb | 0.44 (0.21); −0.14c | .03 | 0.43 (0.21); 0.14c | 0.04 | 0.42 (0.21); 0.14c | .04 |
| b2 | Patient activation follow-up | Medication adherence follow-upd | −0.04 (0.02); −0.16c | .02 | −0.004 (0.02); −0.15c | 0.02 | −0.04 (0.02); −0.16c | .02 |
| b1 | Medication adherence follow-up | Rate of change in outcome | 0.04 (0.02); 0.26c | .05 | 0.04 (0.17); 0.05c | 0.80 | 1.08 (0.53); 0.40c | .04 |
A1 = glycated hemoglobin; LDL = low-density lipoprotein; PDM = participatory decision making.
Note: See Figure 1▶ for path descriptions.
aMeasured by Kaplan-Greenfield scale.
bMeasured by Lorig communication scale.
cStandardized regression coefficient.
dMeasured by Morisky scale.